Complications After Systematic, Random, and Image-guided Prostate Biopsy.

CONTEXT Prostate biopsy (PB) represents the gold standard method to confirm the presence of cancer. In addition to traditional random or systematic approaches, a magnetic resonance imaging (MRI)-guided technique has been introduced recently. OBJECTIVE To perform a systematic review of complications after transrectal ultrasound (TRUS)-guided, transperineal, and MRI-guided PB. EVIDENCE ACQUISITION We performed a systematic literature search of Web of Science, Embase, and Scopus databases up to October 2015, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Complications and mortality following random, systematic, and image-guided PBs were reviewed. Eighty-five references were included. EVIDENCE SYNTHESIS The most frequent complication after PB was minor and self-limiting bleeding (hematuria and hematospermia), regardless of the biopsy approach. Occurrence of rectal bleeding was comparable for traditional TRUS-guided and image-guided PBs. Almost 25% of patients experienced lower urinary tract symptoms, but only a few had urinary retention, with higher rates after a transperineal approach. Temporary erectile dysfunction was not negligible, with a return to baseline after 1-6 mo. The incidence of infective complications is increasing, with higher rates among men with medical comorbidities and older age. Transperineal and in-bore MRI-targeted biopsy may reduce the risk of severe infectious complications. Mortality after PB is uncommon, regardless of biopsy technique. CONCLUSIONS Complications after PB are frequent but often self-limiting. The incidence of hospitalization due to severe infections is continuously increasing. The patient's general health status, risk factors, and likelihood of antimicrobial resistance should be carefully appraised before scheduling a PB. PATIENT SUMMARY We reviewed the variety and incidence of complications after prostate biopsy. Even if frequent, complications seldom represent a problem for the patient. The most troublesome complications are infections. To minimize this risk, the patient's medical condition should be carefully evaluated before biopsy.

[1]  R. Sutherland,et al.  Outcomes of transperineal template‐guided prostate biopsy in 409 patients , 2013, BJU international.

[2]  S. Yip,et al.  Randomized controlled trial of antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy. , 2012, Chinese medical journal.

[3]  J. Raman,et al.  Complications following prostate needle biopsy requiring hospital admission or emergency department visits – experience from 1000 consecutive cases , 2012, BJU international.

[4]  T. Franiel,et al.  MRI-guided core needle biopsy of the prostate: acceptance and side effects. , 2015, Diagnostic and interventional radiology.

[5]  K. Ghani,et al.  Bleeding after transrectal ultrasonography‐guided prostate biopsy: a study of 7‐day morbidity after a six‐, eight‐ and 12‐core biopsy protocol , 2004, BJU international.

[6]  J. Fierer,et al.  Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. , 2012, Urology.

[7]  A. Cheng,et al.  The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy‐related infection over 5 years , 2015, BJU international.

[8]  J. Pépin,et al.  Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? , 2012, European urology.

[9]  F. Sanguedolce,et al.  Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel. , 2013, Urologic oncology.

[10]  E. Barret,et al.  Transperineal template‐guided mapping biopsy of the prostate , 2015, International journal of urology : official journal of the Japanese Urological Association.

[11]  J. Oh,et al.  Control of infective complications of transrectal prostate biopsy. , 2014, Surgical infections.

[12]  A. Gross,et al.  Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper. , 2014, The Journal of urology.

[13]  P. Vera,et al.  Rectal swab testing before prostate biopsy: experience in a VA Medical Center urology practice , 2015, Prostate Cancer and Prostatic Disease.

[14]  A. Kural,et al.  Doppler ultrasonography-guided pelvic plexus block before systematic needle biopsy of the prostate: A prospective randomized study. , 2009, Urology.

[15]  F. Bruyère,et al.  Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy. , 2015, The Journal of urology.

[16]  J. Margolick,et al.  A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. , 2012, The Journal of urology.

[17]  Nathan Lawrentschuk,et al.  Transperineal biopsy of the prostate—is this the future? , 2013, Nature Reviews Urology.

[18]  F. Aragona,et al.  Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. , 2013, Urology.

[19]  Z. Tandoğdu,et al.  Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate. , 2014, Urology.

[20]  P. Han,et al.  Reducing the risk of infection for transrectal prostate biopsy with povidone–iodine: a systematic review and meta-analysis , 2014, International Urology and Nephrology.

[21]  A. Charlett,et al.  Adding amikacin to fluoroquinolone‐based antimicrobial prophylaxis reduces prostate biopsy infection rates , 2011, BJU international.

[22]  David C. Miller,et al.  A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy. , 2015, The Journal of urology.

[23]  Masood Khan,et al.  The role of a standardized 36 core template‐assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography‐guided prostate biopsies , 2012, BJU international.

[24]  Kemal Tuncali,et al.  Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. , 2015, Radiology.

[25]  H. Šošić,et al.  Lidocaine Suppository for Transrectal Ultrasound-Guided Biopsy of the Prostate: A Prospective, Double-Blind, Randomized Study , 2011, Urologia Internationalis.

[26]  P. Scardino,et al.  Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. , 2014, The Journal of urology.

[27]  H Ballentine Carter,et al.  Complications after prostate biopsy: data from SEER-Medicare. , 2011, The Journal of urology.

[28]  D Andrew Loblaw,et al.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. , 2010, The Journal of urology.

[29]  F. Montorsi,et al.  Comparison of a 3‐day with a 1‐day regimen of an extended‐release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate , 2007, BJU international.

[30]  M. Roobol,et al.  Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. , 2012, European urology.

[31]  F. Aragona,et al.  Prostate biopsy: results and advantages of the transperineal approach—twenty-year experience of a single center , 2014, World Journal of Urology.

[32]  G. Nabi,et al.  Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer , 2014, World Journal of Urology.

[33]  L. Vyas,et al.  Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases , 2014, BJU international.

[34]  M. Emberton,et al.  Hospital admissions after transrectal ultrasound‐guided biopsy of the prostate in men diagnosed with prostate cancer: A database analysis in England , 2015, International journal of urology : official journal of the Japanese Urological Association.

[35]  S. Berndt,et al.  Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. , 2012, The Journal of urology.

[36]  D. Moon,et al.  Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category? , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[37]  J. Thrasher,et al.  A prospective study of erectile function after transrectal ultrasonography‐guided prostate biopsy , 2015, BJU international.

[38]  M. Soloway,et al.  Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study , 2007, Prostate Cancer and Prostatic Diseases.

[39]  F. Saad,et al.  Mortality at 120 days after prostatic biopsy: A population‐based study of 22,175 men , 2008, International journal of cancer.

[40]  Chris Metcalfe,et al.  Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study , 2012, BMJ : British Medical Journal.

[41]  Kwangsung Park,et al.  The preventive effect of tamsulosin on voiding dysfunction after prostate biopsy: a prospective, open-label, observational study , 2015, International Urology and Nephrology.

[42]  L. Carmignani,et al.  Cephalosporins periprostatic injection: are really effective on infections following prostate biopsy? , 2012, International Urology and Nephrology.

[43]  R. Autorino,et al.  Combination of perianal-intrarectal lidocaine-prilocaine cream and periprostatic nerve block for pain control during transrectal ultrasound guided prostate biopsy: a randomized, controlled trial. , 2009, The Journal of urology.

[44]  OhJong Jin,et al.  Control of infective complications of transrectal prostate biopsy. , 2014 .

[45]  Yair Lotan,et al.  Systematic review of complications of prostate biopsy. , 2013, European urology.

[46]  T. Tammela,et al.  No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer , 2011, BJU international.

[47]  M. Roobol,et al.  Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. , 2002, Urology.

[48]  H. Parnes,et al.  Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial , 2014, BJU international.

[49]  F. Şimşek,et al.  Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy. , 2008, European urology.

[50]  K. Akakura,et al.  Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events , 2015, International Journal of Clinical Oncology.

[51]  N. Lawrentschuk,et al.  Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? , 2014, BJU international.

[52]  C. Cosentino,et al.  Pelvic plexus block is more effective than periprostatic nerve block for pain control during office transrectal ultrasound guided prostate biopsy: a single center, prospective, randomized, double arm study. , 2012, The Journal of urology.

[53]  K. Dewbury,et al.  Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. , 2005, Clinical radiology.

[54]  C. D. de Jesus,et al.  Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy , 2015, International braz j urol : official journal of the Brazilian Society of Urology.

[55]  Georg Bartsch,et al.  Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. , 2004, The Journal of urology.

[56]  Emily Vertosick,et al.  The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. , 2014, The Journal of urology.

[57]  Y. Aslan,et al.  Association of prostate volume with voiding impairment and deterioration in quality of life after prostate biopsy. , 2014, Urology.

[58]  J. Margolick,et al.  Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy , 2013, BJU international.

[59]  F. Sanguedolce,et al.  Combined perianal‐intrarectal (PI) lidocaine‐prilocaine (LP) cream and lidocaine‐ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy , 2012, BJU international.

[60]  F. Montorsi,et al.  Topical prilocaine–lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: Results from a prospective randomized trial , 2008 .

[61]  O. Gofrit,et al.  A single dose of 240 mg gentamicin during transrectal prostate biopsy significantly reduces septic complications. , 2013, Urology.

[62]  Pär Stattin,et al.  Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy. , 2014, The Journal of urology.

[63]  S. Byun,et al.  Effect of intraprostatic local anesthesia during transrectal ultrasound guided prostate biopsy: comparison of 3 methods in a randomized, double-blind, placebo controlled trial. , 2007, The Journal of urology.

[64]  K. Fujita,et al.  Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. , 2009, The Journal of urology.

[65]  J. Hwa,et al.  Complications of Transrectal Ultrasound-Guided Prostate Biopsy: Impact of Prebiopsy Enema , 2014, Korean journal of urology.

[66]  C. Roehrborn,et al.  Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. , 2013, The Journal of urology.

[67]  A. Larcher,et al.  Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy. , 2013, Urology.

[68]  T. Polascik,et al.  Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy. , 2013, Urology.

[69]  Samuel K. Park,et al.  Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. , 2014, The Journal of urology.

[70]  B. Leibovich,et al.  Histology in mixed germ cell tumors. Is there a favorite pairing? , 2004, The Journal of urology.

[71]  C. Catalano,et al.  MR imaging-guided prostate biopsy: technical features and preliminary results , 2015, La radiologia medica.

[72]  E. Klein,et al.  For Single Dosing, Levofloxacin Is Superior to Ciprofloxacin When Combined With an Aminoglycoside in Preventing Severe Infections After Prostate Biopsy. , 2015, Urology.

[73]  Z. Tandoğdu,et al.  Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. , 2013, European urology.

[74]  N. Nørgaard,et al.  Antibiotic prophylaxis for transrectal prostate biopsy-a new strategy. , 2014, The Journal of antimicrobial chemotherapy.

[75]  K. Sarıca,et al.  Does metabolic syndrome increase the risk of infective complications after prostate biopsy? A critical evaluation , 2015, International Urology and Nephrology.

[76]  L. Mermel,et al.  Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study. , 2015, Urology.

[77]  M. Brock,et al.  The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study. , 2010, The Journal of urology.

[78]  F. Valent,et al.  Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. , 2007, Urology.

[79]  V. Iremashvili,et al.  Periprostatic local anesthesia with pudendal block for transperineal ultrasound-guided prostate biopsy: a randomized trial. , 2010, Urology.

[80]  P. Carroll,et al.  The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. , 2012, The Journal of urology.

[81]  O. Visnjevac,et al.  Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies. , 2015, Urology.

[82]  Christiaan G Overduin,et al.  MRI-Guided Biopsy for Prostate Cancer Detection: A Systematic Review of Current Clinical Results , 2013, Current Urology Reports.

[83]  B. Helfand,et al.  The Impact of Prostate Biopsy on Urinary Symptoms, Erectile Function, and Anxiety , 2012, Current Urology Reports.

[84]  D. He,et al.  Addition of intrarectal local analgesia to periprostatic nerve block improves pain control for transrectal ultrasonography‐guided prostate biopsy: A systematic review and meta‐analysis , 2015, International journal of urology : official journal of the Japanese Urological Association.

[85]  D. Volanis,et al.  Safety of ultrasound-guided transrectal extended prostate biopsy in patients receiving low-dose aspirin. , 2010, International braz j urol : official journal of the Brazilian Society of Urology.

[86]  E. Rutherford,et al.  Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. , 2012, Clinical radiology.